SANDOZ OSELTAMIVIR

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 82b955e216c95871
Drug Approval Canada Name: SANDOZ OSELTAMIVIR
Product Name: SANDOZ OSELTAMIVIR
Status: Marketed
Status Date: 2025-04-15
Original Market Date: 2020-10-02
Din: 02504006
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.28
Atc Original: J05AH02 OSELTAMIVIR
Atc Name: j 05 ah 02
Aig Number: 0139501003
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)

30 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

82b955e216c95871

Type

Standard